CDK4 and chondrosarcoma: Similarly, CDK4, linked to cell cycle regulation and associated with a poor prognosis in chondrosarcoma, can be targeted by palbociclib or CDK4-specific siRNA, which significantly reduces tumor cell proliferation and spread via cell cycle arrest.